Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zheran Liu

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
Frontiers in Pharmacology|October 16, 2018
PAI-1 Exacerbates White Adipose Tissue Dysfunction and Metabolic Dysregulation in High Fat Diet-Induced ObesityLin Wang, Liyuan Chen, Zheran Liu, et al.
Cancer Management and Research|June 29, 2026
Baseline Nutritional Indices as Prognostic Indicators in Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma Treated with the PD-L1 Inhibitor KL-A167: A Secondary Analysis of the KL-A167 TrialHuilin Li, Zheran Liu, Jiacheng Li, et al.
International Journal of Cancer|September 24, 2021
Association between fish oil supplementation and cancer risk according to fatty fish consumption: A large prospective population-based cohort study using UK BiobankZheran Liu, Yaxin Luo, Jianjun Ren, et al.
Cancer Immunology, Immunotherapy : CII|September 29, 2025
Correction: Metastatic sites of baseline as predictors in recurrent or metastatic nasopharyngeal carinoma treated with PD-L1 inhibitor: a secondary analysis of multicenter, single-arm, phase II study (KL-A167)Yuantai Li, Yu Min, Zhigong Wei, et al.
Cancer Immunology, Immunotherapy : CII|January 3, 2025
Metastatic sites of baseline as predictors in recurrent or metastatic nasopharyngeal carinoma treated with PD-L1 inhibitor: a secondary analysis of multicenter, single-arm, phase II study (KL-A167)Yuantai Li, Yu Min, Zhigong Wei, et al.
JAMA Network Open|December 15, 2025
Multidisciplinary Team Support for Patients With Head and Neck Cancer Receiving Radiotherapy: A Randomized Clinical TrialYiyan Pei, Jingjing Wang, Juejin Li, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Frontiers in Pharmacology|October 16, 2018
PAI-1 Exacerbates White Adipose Tissue Dysfunction and Metabolic Dysregulation in High Fat Diet-Induced ObesityLin Wang, Liyuan Chen, Zheran Liu, et al.
Cancer Management and Research|June 29, 2026
Baseline Nutritional Indices as Prognostic Indicators in Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma Treated with the PD-L1 Inhibitor KL-A167: A Secondary Analysis of the KL-A167 TrialHuilin Li, Zheran Liu, Jiacheng Li, et al.
International Journal of Cancer|September 24, 2021
Association between fish oil supplementation and cancer risk according to fatty fish consumption: A large prospective population-based cohort study using UK BiobankZheran Liu, Yaxin Luo, Jianjun Ren, et al.
Cancer Immunology, Immunotherapy : CII|September 29, 2025
Correction: Metastatic sites of baseline as predictors in recurrent or metastatic nasopharyngeal carinoma treated with PD-L1 inhibitor: a secondary analysis of multicenter, single-arm, phase II study (KL-A167)Yuantai Li, Yu Min, Zhigong Wei, et al.
Cancer Immunology, Immunotherapy : CII|January 3, 2025
Metastatic sites of baseline as predictors in recurrent or metastatic nasopharyngeal carinoma treated with PD-L1 inhibitor: a secondary analysis of multicenter, single-arm, phase II study (KL-A167)Yuantai Li, Yu Min, Zhigong Wei, et al.
JAMA Network Open|December 15, 2025
Multidisciplinary Team Support for Patients With Head and Neck Cancer Receiving Radiotherapy: A Randomized Clinical TrialYiyan Pei, Jingjing Wang, Juejin Li, et al.
Pageof 8